Competing risk analyse: Difference between revisions

From Wikistatistiek
Jump to navigation Jump to search
No edit summary
Line 5: Line 5:
*[http://www.nature.com/bmt/journal/v40/n4/pdf/1705727a.pdf Competing risk analysis using R: an easy guide for clinicians - Technical Report, L Scrucca, A Santucci and F Aversa, Bone Marrow Transplantation (2007) 40, 381-387]
*[http://www.nature.com/bmt/journal/v40/n4/pdf/1705727a.pdf Competing risk analysis using R: an easy guide for clinicians - Technical Report, L Scrucca, A Santucci and F Aversa, Bone Marrow Transplantation (2007) 40, 381-387]
*[http://www.ntvg.nl/publicatie/concurrerende-risico%E2%80%99s-klinisch-onderzoek Concurrerende risico's in klinisch onderzoek, Rob C.M. van Kruijsdijk, Marinus J.C. Eijkemans en Frank L.J. Visseren, Ned Tijdschr Geneeskd. 2012;156:A5176]
*[http://www.ntvg.nl/publicatie/concurrerende-risico%E2%80%99s-klinisch-onderzoek Concurrerende risico's in klinisch onderzoek, Rob C.M. van Kruijsdijk, Marinus J.C. Eijkemans en Frank L.J. Visseren, Ned Tijdschr Geneeskd. 2012;156:A5176]
*[http://www.ncbi.nlm.nih.gov/pubmed/21059831 Verduijn M, Grootendorst DC, Dekker FW, Jager KJ, le Cessie S. The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. Nephrol Dial Transplant. 2011 Jan;26(1):56-61. doi: 10.1093/ndt/gfq661]





Revision as of 08:33, 27 May 2015